These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29048945)

  • 1. Cell Density Affects the Detection of Chk1 Target Engagement by the Selective Inhibitor V158411.
    Geneste CC; Massey AJ
    SLAS Discov; 2018 Feb; 23(2):144-153. PubMed ID: 29048945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high content, high throughput cellular thermal stability assay for measuring drug-target engagement in living cells.
    Massey AJ
    PLoS One; 2018; 13(4):e0195050. PubMed ID: 29617433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase.
    Wayne J; Brooks T; Massey AJ
    Oncotarget; 2016 Dec; 7(51):85033-85048. PubMed ID: 27829224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design.
    Massey AJ; Stokes S; Browne H; Foloppe N; Fiumana A; Scrace S; Fallowfield M; Bedford S; Webb P; Baker L; Christie M; Drysdale MJ; Wood M
    Oncotarget; 2015 Nov; 6(34):35797-812. PubMed ID: 26437226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chk1 inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers.
    Bryant C; Rawlinson R; Massey AJ
    BMC Cancer; 2014 Aug; 14():570. PubMed ID: 25104095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy.
    Massey AJ
    Cancer Lett; 2016 Dec; 383(1):41-52. PubMed ID: 27693461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1.
    McNulty DE; Bonnette WG; Qi H; Wang L; Ho TF; Waszkiewicz A; Kallal LA; Nagarajan RP; Stern M; Quinn AM; Creasy CL; Su DS; Graves AP; Annan RS; Sweitzer SM; Holbert MA
    SLAS Discov; 2018 Jan; 23(1):34-46. PubMed ID: 28957646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells.
    Bryant C; Scriven K; Massey AJ
    Mol Cancer; 2014 Jun; 13():147. PubMed ID: 24913641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-Time Cellular Thermal Shift Assay to Monitor Target Engagement.
    Sanchez TW; Ronzetti MH; Owens AE; Antony M; Voss T; Wallgren E; Talley D; Balakrishnan K; Leyes Porello SE; Rai G; Marugan JJ; Michael SG; Baljinnyam B; Southall N; Simeonov A; Henderson MJ
    ACS Chem Biol; 2022 Sep; 17(9):2471-2482. PubMed ID: 36049119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC1 and DNA-PKcs as novel molecular determinants of sensitivity to Chk1 inhibition.
    Massey AJ; Stephens P; Rawlinson R; McGurk L; Plummer R; Curtin NJ
    Mol Oncol; 2016 Jan; 10(1):101-12. PubMed ID: 26471831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of selective target engagement by small-molecule sphingosine kinase inhibitors using the Cellular Thermal Shift Assay (CETSA).
    Hengst JA; Dick TE; Smith CD; Yun JK
    Cancer Biol Ther; 2020 Sep; 21(9):841-852. PubMed ID: 32835586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative target engagement of RIPK1 in human whole blood via the cellular thermal shift assay for potential pre-clinical and clinical applications.
    Patel S; Karlsson M; Klahn JT; Gambino F; Costa H; McGuire KA; Baumgartner CK; Williams J; Sandoz S; Kath JE
    SLAS Discov; 2024 Mar; 29(2):100135. PubMed ID: 38101572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments.
    Rawlinson R; Massey AJ
    BMC Cancer; 2014 Jul; 14():483. PubMed ID: 24996846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer.
    Alsubhi N; Middleton F; Abdel-Fatah TM; Stephens P; Doherty R; Arora A; Moseley PM; Chan SY; Aleskandarany MA; Green AR; Rakha EA; Ellis IO; Martin SG; Curtin NJ; Madhusudan S
    Mol Oncol; 2016 Feb; 10(2):213-23. PubMed ID: 26459098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies.
    Martinez Molina D; Nordlund P
    Annu Rev Pharmacol Toxicol; 2016; 56():141-61. PubMed ID: 26566155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro.
    Wang Z; Førsund MS; Trope CG; Nesland JM; Holm R; Slipicevic A
    Cancer Med; 2018 Aug; 7(8):3955-3964. PubMed ID: 29963769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A widely-applicable high-throughput cellular thermal shift assay (CETSA) using split Nano Luciferase.
    Martinez NJ; Asawa RR; Cyr MG; Zakharov A; Urban DJ; Roth JS; Wallgren E; Klumpp-Thomas C; Coussens NP; Rai G; Yang SM; Hall MD; Marugan JJ; Simeonov A; Henderson MJ
    Sci Rep; 2018 Jun; 8(1):9472. PubMed ID: 29930256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target Engagement of Small Molecules: Thermal Profiling Approaches on Different Levels.
    Reckzeh ES; Brockmeyer A; Metz M; Waldmann H; Janning P
    Methods Mol Biol; 2019; 1888():73-98. PubMed ID: 30519941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products.
    Tu Y; Tan L; Tao H; Li Y; Liu H
    Phytomedicine; 2023 Jul; 116():154862. PubMed ID: 37216761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of thienopyridinones as Chk1 inhibitors.
    Song P; Peng P; Han M; Cao X; Ma X; Liu T; Zhou Y; Hu Y
    Bioorg Med Chem; 2014 Sep; 22(17):4882-92. PubMed ID: 25042558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.